Case Presets & Specimen Controls
Metabolic Panel & Co-Ingestion Screen
| Compound | Classification | Result | Status |
|---|---|---|---|
| Ethanol | CNS Depressant | 0.18 g/dL | Elevated Ante-Mortem |
Equilibrium Verification & Kinetic Curve
Vitreous Concordance Confirmed
Vitreous / Blood Ratio
1.17
Expected: 1.10 - 1.25
Est. Clearance Time
10.6 hrs
Zero-Order Elimination
Risk Assessment
Severe Impairment
>0.15 g/dL High Ataxia
Scientific Reporting Assessment
CLINICAL REF: ST-2026
Report confirms verified ante-mortem alcohol presence with concurrent vitreous validation ruling out post-mortem microbial artifact.
Consistent with ante-mortem distribution equilibrium (Vitreous/Blood ratio 1.17 within standard 1.10-1.25 range)
Ready for structured export